Novelix Pharmaceuticals Surges 5% Today, Reaches New 52-Week High of Rs. 66.82
Novelix Pharmaceuticals Ltd is experiencing notable buying interest, with the stock reaching a new 52-week high today. It has shown substantial gains over the past week and month, significantly outperforming the Sensex. The stock has consistently traded above key moving averages, reflecting a strong upward trend.
Novelix Pharmaceuticals Ltd is currently witnessing significant buying activity, with the stock gaining 5.00% today, contrasting sharply with the Sensex's decline of 0.23%. Over the past week, Novelix has surged by 21.45%, while the Sensex managed only a modest increase of 1.05%. The stock's performance over the last month shows a remarkable rise of 51.35%, significantly outperforming the Sensex, which rose just 0.95%.Notably, Novelix Pharmaceuticals has achieved a new 52-week high of Rs. 66.82 today, following a strong open with a gap up of 5%. The stock has been on a positive trajectory, recording consecutive gains for the last five days, accumulating a total return of 21.45% during this period. It has consistently traded above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a robust upward trend.
The strong buying pressure may be attributed to various factors, including positive market sentiment and the stock's impressive performance metrics over different time frames, particularly its year-to-date increase of 0.00% compared to the Sensex's 8.46%.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
